<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Feiya Ou</title>
  <meta name="description" content="Feiya Ou — Immunology PhD at WashU. Neuroimmunology, enhancer biology, and transcriptional regulation.">
  <style>
    /* Minimal, readable, no frameworks */
    :root{
      --fg:#222; --bg:#fff; --muted:#555; --link:#0645ad; --max:820px; --border:#e6e6e6
    }
    *{box-sizing:border-box}
    html{font-size:16px}
    body{margin:0; color:var(--fg); background:var(--bg); font-family: system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji"; line-height:1.6}
    .wrap{max-width:var(--max); margin:0 auto; padding:24px}
    header{padding:28px 0 8px; border-bottom:1px solid var(--border)}
    h1{font-size:1.9rem; margin:.2rem 0}
    .tag{color:var(--muted); margin:.2rem 0 .6rem}
    .avatar{width:200px; height:200px; border-radius:50%; object-fit:cover; border:1px solid var(--border)}
    nav{display:flex; gap:14px; flex-wrap:wrap; margin:.4rem 0 1rem}
    nav a{color:var(--link); text-decoration:none; padding:.2rem .4rem; border-radius:6px}
    nav a:hover{background:#f5f5f5}
    main section{padding:18px 0; border-bottom:1px solid var(--border)}
    h2{font-size:1.25rem; margin:0 0 .6rem}
    h3{font-size:1rem; margin:.8rem 0 .2rem}
    ul{margin:.4rem 0 .8rem 1.2rem}
    li{margin:.28rem 0}
    a{color:var(--link)}
    .muted{color:var(--muted)}
    .small{font-size:.95rem}
    footer{padding:18px 0; color:var(--muted)}
    /* Mobile niceties */
    @media (max-width:520px){
      .wrap{padding:18px}
      nav{gap:10px}
    }
  </style>
</head>
<body>
  <div class="wrap">
    <header>
      <div class="top">
        <img class="avatar" src="Feiya_Ou_photo.png" alt="Portrait of Feiya Ou" />
        <div>
          <h1>Feiya Ou (欧非亚)</h1>
          <div class="tag small">I'm an Immunology PhD Candidate at Washington University in St. Louis, currently interested in genetics and transcription.</div>
        </div>
      </div>
      <nav aria-label="Primary">
        <a href="#about">About</a>
        <a href="#research">Research</a>
        <a href="#publications">Publications</a>
        <a href="#cv">CV</a>
        <a href="#contact">Contact</a>
      </nav>
    </header>

    <main>
      <section id="about">
        <h2>About</h2>
        <p>
          I’m finishing my PhD in the Murphy Lab at Washington University in St. Louis (WashU). I have focused my PhD work on molecular circuits that control cell fates in the immune system, particularly the <em>Irf8</em> +32-kb enhnacer in cDC1 fate commitment and the <em>Zeb2</em> -165-kb enhancer in multiple lymphoid and myeloid lineages. I’m seeking a postdoc in <strong>transcription regulation</strong>.
        </p>
        <p class="small muted">
          Interests: molecular and physical mechanisms for enhancer-promoter contact, enhancer switching, and silencers.
        </p>
      </section>

      <section id="research">
        <h2>Research</h2>
        <h3>KITL/FLT3L culture system</h3>
        <p class="small">I developed a two-step culture protocol that increases cDC1 yield ~10-fold over standard methods. (Download an FAQ document about this protocol <a href="KITL_FLT3L_culture_FAQ.docx">here</a>)</p>
        <h3><em>Irf8</em> +32-kb enhancer</h3>
                <p class="small">I generated Irf8 +32H/H mice, which carry an “optimized” version of the Irf8 +32-kb enhancer featuring multiple high-affinity AICEs. These mice exhibit erroneous IRF8 autoactivation in cDC2 progenitors, cDC2 lineage redirection, and paradoxically reduced IRF8 expression in cDC1s. These problems compromise both cDC1- and cDC2-dependent arms of immunity.</p>
        <h3><em>Zeb2</em> -165-kb enhancer</h3>
        <p class="small">I generated ∆E mice lacking three E-boxes in the enhancer. Revealed that E-boxes activate this enhancer in the lymphoid compartment to enable B cell and pDC development, and that E-boxes and CEBP sites together activate this same enhancer in the myeloid compartment to support cDC2 and monocyte development. Also demonstrated that ID2 secures the cDC1 fate by antagonizing E protein activity at the Zeb2 enhancer.</p>
      </section>

      <section id="publications">
        <h2>Selected Publications</h2>
        <ul>
          <li><strong>Ou, F.</strong>, et al. <em>E proteins facilitate Zeb2 expression for balanced lymphoid and myeloid development.</em> <span class="muted">Under Review, Nature Immunology.</span> <a href="https://doi.org/10.21203/rs.3.rs-7455813/v1">preprint</a></li>
          <li><strong>Ou, F.</strong>; Murphy, KM. <em>“What’s in a name?” Clarifying the identity of RORγt+ antigen-presenting cells.</em> <span class="muted">Journal of Experimental Medicine 2025.</span> <a href="https://doi.org/10.1084/jem.20250760">journal</a></li>
          <li><strong>Ou, F.</strong>, et al. <em>Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation.</em> <span class="muted">Nature Immunology 2024.</span> <a href="https://doi.org/10.1038/s41590-024-01976-w">journal</a></li>
          <li><strong>Ou, F.</strong>, st al. <em>Enhanced in vitro type 1 conventional dendritic cell generation via the recruitment of hematopoietic stem cells and early progenitors by Kit ligand.</em> <span class="muted">European Journal of Immunology 2023.</span> <a href="https://doi.org/10.1002/eji.202250201">journal</a></li>
        </ul>
        <p class="small">Full list on <a href="https://scholar.google.com/citations?user=Cd8V0sMAAAAJ&hl=en" target="_blank" rel="noopener">Google Scholar</a></p>
      </section>

      <section id="cv">
        <h2>CV</h2>
        <p class="small">Download my CV <a href="Feiya_Ou_CV_September_2025.docx">here</a></p>
      </section>

      <section id="contact">
        <h2>Contact</h2>
        <p class="small">
          <a href="mailto:feiya.ou@wustl.edu">Email</a> ·
          <a href="https://x.com/FeiyaOu1" target="_blank" rel="noopener">Twitter/X</a> ·
          <a href="https://bsky.app/profile/feiyaou.bsky.social" target="_blank" rel="noopener">Bluesky</a> ·
          <a href="https://www.linkedin.com/in/feiya-ou-309779182/" target="_blank" rel="noopener">LinkedIn</a> ·
          <a href="https://github.com/JoyboyOu" target="_blank" rel="noopener">GitHub</a> ·
          <a href="https://orcid.org/0000-0001-8289-4025" target="_blank" rel="noopener">ORCID</a>
        </p>
      </section>
    </main>

    <footer>
      <div class="small muted">© 2025 Feiya Ou · Built with plain HTML/CSS · Hosted on GitHub Pages · Last updated: September 2025</div>
    </footer>
  </div>

  <script>document.getElementById('yr').textContent = new Date().getFullYear()</script>
</body>
</html>
